4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical versus radiographic progression and overall survival for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) from COU-AA-302
    Meeting Abstract

    Ryan, C. J.; Kheoh, T.; Scher, H. I.; De Porre, P.; Yu, M. K.; Morris, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Evolution in multimodality management of locally advanced rectal cancer
    Meeting Abstract

    Roxburgh, C. S. D.; Strombom, P.; Lynn, P. B.; Cercek, A.; Saltz, L.; Gollub, M. J.; Crane, C. H.; Wu, A. J. C.; Shia, J.; Vakiani, E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Factors and barriers associated with changes in physical activity after cancer diagnosis
    Meeting Abstract

    Romero, S. A. D.; Li, Q. S.; Mao, J. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Use of phenotypic profiling to determine sensitivity of gemcitabine with nab-paclitaxel for front-line treatment of pancreatic cancer
    Meeting Abstract

    Ricigliano, M.; Cooper, B.; Bartlett, A.; Yu, K. H.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Evaluation of a cell viability assay based on cultures of CTICs to identify treatment options in third-line pancreatic cancer
    Meeting Abstract

    Ricigliano, M.; Isacoff, W. H.; Ocean, A. J.; Cooper, B.; Welkie, M.; Bartlett, A.; Yu, K. H.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Sunitinib in patients with metastatic renal cell carcinoma: Clinical outcome according to IMDC risk group
    Meeting Abstract

    Rini, B. I.; Hutson, T. E.; Figlin, R. A.; Lechuga, M.; Valota, O.; Serfass, L.; Casey, M.; Motzer, R. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm)
    Meeting Abstract

    Robson, M. E.; Im, S. A.; Senkus, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N. M.; Armstrong, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)
    Meeting Abstract

    Riaz, N.; Sherman, E. J.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J.; Singh, B.; Morris, L. G.; Wong, R. J.; Tsai, C. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Development of a statin risk communication tool for use in cancer survivors: A pilot
    Meeting Abstract

    Raghunathan, N. J.; Korenstein, D.; Anderson, N.; Adsuar, R.; Tonorezos, E. S.; Oeffinger, K. C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Powles, T.; Fizazi, K.; Gillessen, S.; Drake, C. G.; Rathkopf, D. E.; Narayanan, S.; Green, M. C.; Mecke, A.; Schiff, C.; Sweeney, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save